UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Distinct vascular genomic response of proton and gamma radiation-A pilot investigation

PloS one, 2019-02, Vol.14 (2), p.e0207503-e0207503

2019

Volltextzugriff (PDF)

First‐line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age‐matched general population: A pooled post hoc analysis

HemaSphere, 2024-05, Vol.8 (5), p.e74-n/a

2024

Volltextzugriff (PDF)

Evidence for Radiation-Induced Disseminated Intravascular Coagulation as a Major Cause of Radiation-Induced Death in Ferrets

International journal of radiation oncology, biology, physics, 2014-03, Vol.88 (4), p.940-946

2014

Volltextzugriff (PDF)

Mechanism of hypocoagulability in proton-irradiated ferrets

International journal of radiation biology, 2013-10, Vol.89 (10), p.823-831

2013

Volltextzugriff (PDF)

Analysis of real-world PD-L1 IHC 28-8 and 22C3 pharmDx assay utilisation, turnaround times and analytical concordance across multiple tumour types

Journal of clinical pathology, 2020-10, Vol.73 (10), p.656-664

2020

Volltextzugriff (PDF)

Comparison of hindlimb unloading and partial weight suspension models for spaceflight-type condition induced effects on white blood cells

Advances in space research, 2012-01, Vol.49 (2), p.237-248

2012

Volltextzugriff (PDF)

Real-World Treatment Patterns and Outcomes by Line of Therapy and Race in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated in the United States: Results From the Final Analysis of the Prospective, Observational, informCLL Registry

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24 (9), p.e301-e313

2024

Volltextzugriff (PDF)

Novel targets in head and neck cancer: should we be optimistic?

Clinical cancer research, 2015-02, Vol.21 (3), p.495-497

2015

Volltextzugriff (PDF)

Is disseminated intravascular coagulation the major cause of mortality from radiation at relatively low whole body doses?

Radiation research, 2013-09, Vol.180 (3), p.231-234

2013

Volltextzugriff (PDF)

The effects of proton radiation on the prothrombin and partial thromboplastin times of irradiated ferrets

International journal of radiation biology, 2012-04, Vol.88 (4), p.327-334

2012

Volltextzugriff (PDF)

Effects of a granulocyte colony stimulating factor, Neulasta, in mini pigs exposed to total body proton irradiation

Life sciences in space research, 2015-04, Vol.5, p.13-20

2015

Volltextzugriff (PDF)

Ground-based microgravity and proton radiation exposure alters leukocyte activity

Journal of radiation research, 2014-03, Vol.55 (suppl_1), p.i94-i94

2014

Volltextzugriff (PDF)

Acute effects of solar particle event radiation

Journal of radiation research, 2014-03, Vol.55 (suppl_1), p.i66-i67

2014

Volltextzugriff (PDF)

Initiating First-Line (1L) Ibrutinib (Ibr) in Patients (pts) with Chronic Lymphocytic Leukemia (CLL) Improves Overall Survival (OS) Outcomes to Rates Approximating an Age-Matched Population of ≥65 Years

Blood, 2022-11, Vol.140 (Supplement 1), p.4159-4161

2022

Volltextzugriff (PDF)

Abstract 3993A: Real-world utilization of PD-L1 IHC testing and results across multiple tumor types

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3993-3993A

2019

Volltextzugriff (PDF)

The Effects of Gamma and Proton Radiation Exposure on Hematopoietic Cell Counts in the Ferret Model

Gravitational and space research, 2013-10, Vol.1 (1), p.79-94

2013

Volltextzugriff (PDF)

Analysis of real-world PD-L1 IHC testing for clinical use in patients across multiple tumor types

Journal of clinical oncology, 2019-03, Vol.37 (8_suppl), p.151-151

2019

Volltextzugriff (PDF)

Analysis of real-world PD-L1 testing in patients with urothelial carcinoma

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.447-447

2019

Volltextzugriff (PDF)

Correction: Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway

Molecular cancer, 2024-10, Vol.23 (1), p.233-3, Article 233

2024

Volltextzugriff (PDF)

Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects

Science translational medicine, 2013-02, Vol.5 (171), p.171ra17

2013

Volltextzugriff (PDF)

Long‐term efficacy of first‐line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials

British journal of haematology, 2022-02, Vol.196 (4), p.947-953

2022

Volltextzugriff (PDF)

Tailor: Interventional Study Evaluating Physician's Choice of Ibrutinib Monotherapy or Ibrutinib-Venetoclax Combination Using Dose Modifications and Alternate Dosing Approaches in Patients with Untreated Chronic Lymphocytic Leukemia

Blood, 2023-11, Vol.142 (Supplement 1), p.6564-6564

2023

Volltextzugriff (PDF)

Long‐term efficacy of first‐line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: apooled analysis from four clinical trials

British journal of haematology, 2022-02, Vol.196 (4), p.947-953

2022

Volltextzugriff (PDF)

Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations

Clinical cancer research, 2016-04, Vol.22 (8), p.2009-2019

2016

Volltextzugriff (PDF)

Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway

Molecular cancer, 2015-05, Vol.14 (1), p.99, Article 99

2015

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(40)
Dissertationen
(1)

Sprache

Englisch
(41)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(17)
Oncology
(14)
Humans
(13)
Animals
(10)
Analysis
(6)
Hematology
(6)
Radiation
(6)
Biology
(5)
Cell Line, Tumor
(5)
Female
(5)
Physical Sciences
(5)
Technology
(5)
Health Aspects
(4)
Male
(4)
Mice
(4)
Protons - Adverse Effects
(4)
Radiology, Nuclear Medicine & Medical Imaging
(4)
Solar Activity
(4)
Space Flight
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Distinct vascular genomic response of proton and gamma radiation-A pilot investigation

First‐line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age‐matched general population: A pooled post hoc analysis

Evidence for Radiation-Induced Disseminated Intravascular Coagulation as a Major Cause of Radiation-Induced Death in Ferrets

Mechanism of hypocoagulability in proton-irradiated ferrets

Analysis of real-world PD-L1 IHC 28-8 and 22C3 pharmDx assay utilisation, turnaround times and analytical concordance across multiple tumour types

Comparison of hindlimb unloading and partial weight suspension models for spaceflight-type condition induced effects on white blood cells

Real-World Treatment Patterns and Outcomes by Line of Therapy and Race in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated in the United States: Results From the Final Analysis of the Prospective, Observational, informCLL Registry

Novel targets in head and neck cancer: should we be optimistic?

Is disseminated intravascular coagulation the major cause of mortality from radiation at relatively low whole body doses?

The effects of proton radiation on the prothrombin and partial thromboplastin times of irradiated ferrets

Effects of a granulocyte colony stimulating factor, Neulasta, in mini pigs exposed to total body proton irradiation

Ground-based microgravity and proton radiation exposure alters leukocyte activity

Acute effects of solar particle event radiation

Initiating First-Line (1L) Ibrutinib (Ibr) in Patients (pts) with Chronic Lymphocytic Leukemia (CLL) Improves Overall Survival (OS) Outcomes to Rates Approximating an Age-Matched Population of ≥65 Years

Abstract 3993A: Real-world utilization of PD-L1 IHC testing and results across multiple tumor types

The Effects of Gamma and Proton Radiation Exposure on Hematopoietic Cell Counts in the Ferret Model

Analysis of real-world PD-L1 IHC testing for clinical use in patients across multiple tumor types

Analysis of real-world PD-L1 testing in patients with urothelial carcinoma

Correction: Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway

Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects

Long‐term efficacy of first‐line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials

Tailor: Interventional Study Evaluating Physician's Choice of Ibrutinib Monotherapy or Ibrutinib-Venetoclax Combination Using Dose Modifications and Alternate Dosing Approaches in Patients with Untreated Chronic Lymphocytic Leukemia

Long‐term efficacy of first‐line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: apooled analysis from four clinical trials

Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations

Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway

Suchergebnisse filtern